SAGED

“I’m not even 40 but I feel like I’m 80.” Johanna presented with chronic neuropathic pain and spasticity in her hands and feet due to multiple sclerosis. It was impacting her mobility and sleep, the effects of which had flowed into her career and finances. Living with her parents while awaiting NDIS support, medical cannabis seemed like a promising treatment option but posed a risk with her Natalizumab use, requiring sound management to avoid potential hepatic injury. Financial constraints added complexity to accessing medical cannabis. Discover how Johanna's team crafted an affordable and effective medical cannabis treatment, addressing her pain, sleep issues, and restoring her sense of self. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Demonstrate an understanding of the pathophysiology of MS Discuss common treatment options for MS Discuss how cannabinoid-based therapies may be an effective treatment option for symptom management in patients with MS Explain the TGA guidance for providing medical cannabis as a treatment for patients with MS Collect detailed patient information Apply critical safety considerations/risk mitigation strategies for patients presenting with potential for hepatic injury Discuss product usage and critical safety considerations with patients in patient-centred care

Violet, a seventy-seven year old woman, is in palliative care and undergoing radiation therapy.  As she enters her end of life (EOL) period, she's looking to medical cannabis to improve her comfort and alleviate the pain caused by the side effects of the other therapies she's undergoing. In this case study, we explore how Violet's team devised a suitable treatment plan that addressed her side effects and improved her quality of life (QOL) during her EOL period. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Define the palliative approach to care and outline key clinical assessments  Discuss the potential benefits and limitations of medical cannabis as a treatment option for symptomatic management in palliative care Identify suitable candidates for medical cannabis treatment Apply critical safety considerations/risk mitigation strategies for patients using medical cannabis in palliative care Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in palliative care Discuss product usage and critical safety considerations with patients in patient-centred care

Noel is a 57-year-old military veteran who developed PTSD and chronic pain due to several injuries sustained during service. Despite trialling several conventional treatment options, Noel is still experiencing debilitating mood symptoms that affect his sleep, as well as chronic pain from the injuries he sustained. In this case study, we explore how Dr. Xie prescribed medical cannabis in Noel's treatment plan. Preview this module by watching the video above. Estimated Duration: 1 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Explain the pathophysiology of PTSD and identify common management strategies  Discuss the potential benefits and limitations of medical cannabis as a treatment option for symptoms of PTSD Identify suitable candidates for medical cannabis treatment Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in the management of PTSD Devise treatment plans that consider patient safety and minimise risk

Trigeminal neuralgia (TN) is a painful condition characterised by severe electric shock-like or burning pain in the craniofacial tissues that connect to the trigeminal nerve. Anne, a 52 year old with TN, seeks treatment for chronic facial pain with regular nightly flare ups. Due to the pain, Anne’s been feeling nauseated and finding it difficult to sleep, and hasn’t been able to fully participate in daily life. Despite trialling and using a range of conventional medications, and regularly consulting specialists, Anne hasn’t found relief for her symptoms. She’s considering medical cannabis to manage her pain, nausea and sleep so she can get back to work and life. In this case study, we explore how Anne’s team incorporated medical cannabis products in her treatment plan. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Explain the pathophysiology of trigeminal neuralgia and identify common management strategies  Discuss the potential benefits and limitations of medical cannabis as a treatment option for symptoms of trigeminal neuralgia Identify suitable candidates for medical cannabis treatment Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in the management of symptoms of trigeminal neuralgia Devise treatment plans that consider patient safety and minimise risk Offer effective patient education and treatment advice on the therapeutic use of medical cannabis

Twenty-six-year-old Lexi has primary vaginismus that causes vaginal spasming and burning in the vaginal canal during penetration. As a result, Lexi is unable to use tampons and has developed secondary anxiety around sexual intercourse. Lexi has trialled several first-line treatments, but none were suitable due to lack of efficacy and/or Lexi's work schedule. Lexi continues to experience vaginal pain during sex. In this case study, we explore how Dr. Xie prescribed medical cannabis products to reduce Lexi's pain and ease her anxiety towards sexual intercourse. Preview this case study by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this case study, you’ll be able to: Explain the pathophysiology of vaginismus and identify common management strategies  Discuss the potential benefits and limitations of medical cannabis as a treatment option for symptoms of vaginismus  Identify suitable candidates for medical cannabis treatment Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in the management of vaginismus  Devise treatment plans that consider patient safety and minimise risk

Hayley, a 37-year-old female, presents with chronic pain and combined-type ADHD.  Despite her diagnosis 27 years prior, her ADHD is unmanaged, and she’s seeking particular help with attention, anxiety and sleep, as well as pain management for chronic lower back and shoulder pain. In this case study, we explore how Hayley’s team prescribed a combination of medical cannabis products, including medicated edibles, to treat Hayley’s symptoms and restore her quality of life. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Explain how and why ADHD and chronic pain affects patients Discuss the potential benefits and limitations of medical cannabis as a treatment option for ADHD and pain symptoms Identify suitable candidates for medical cannabis treatment Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in ADHD and chronic pain symptom management Devise treatment plans that consider patient safety and minimise risk Offer effective patient education and treatment advice on the therapeutic use of medical cannabis

Chad, a 19-year-old autistic male, seeks supports to help him manage his meltdowns and secondary anxiety and depression.  Despite already implementing a wide range of supports and medications to alleviate his distress and manage his aggressive behaviour, Chad's mother Linda, is looking to medical cannabis to supplement his current plan. In this case study, we explore how Chad's team prescribed a combination of medical cannabis products to address Chad's distress and improve his quality of life. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Define "neurotype" Explain the purpose of neuroaffirming patient-centric practice Identify strategies to deliver neuroaffirming practice Explain the similarities and differences between autistic and allistic individuals Discuss conventional treatment options for managing distress in autistic individuals Discuss the potential benefits and limitations of medical cannabis as a treatment option for autistic individuals with anxiety and depression Identify suitable candidates for medical cannabis treatment Facilitate clinical discussions with patients and carers around medical cannabis as a therapeutic option for distress secondary to autistic traits Devise treatment plans that consider patient safety and minimise risk Offer effective patient education and treatment advice on the therapeutic use of medical cannabis

Forty-eight-year-old David is seeking relief for depression and anxiety secondary to borderline personality disorder (BPD). David is currently using first-line treatments, but these have proved ineffective as David's still experiencing unwanted symptoms. In this case study, we explore how Dr. Xie prescribed medical cannabis products to help alleviate David’s symptoms and improve his overall quality of life. Preview this module by watching the video above. Estimated Duration: 1 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Explain the pathophysiology of borderline personality disorder and identify common management strategies  Discuss the potential benefits and limitations of medical cannabis as a treatment option for symptoms of borderline personality disorder Identify suitable candidates for medical cannabis treatment Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in the management of symptoms of borderline personality disorder Devise treatment plans that consider patient safety and minimise risk

Lucy, a 60-year-old female, presents with a frozen shoulder with secondary constant pain with flare ups on movement. Her quality of life is severely impacted, due to reduced range of motion in her shoulder, and she’s now unable to work. This is causing anxiety and poor sleep quality.  In this case study, we explore how Lucy’s team prescribed a combination of medical cannabis products to manage her pain symptoms and restore her quality of life. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Explain the pathophysiology of chronic pain, anxiety and sleep issues  and identify common management strategies  Discuss the potential benefits and limitations of medical cannabis as a treatment option for patients with chronic pain, anxiety and sleep issues Identify suitable candidates for medical cannabis treatment Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management of chronic pain, anxiety and sleep issues Devise treatment plans that consider patient safety and minimise risk Offer effective patient education and treatment advice on the therapeutic use of medical cannabis

Marta, a 49-year-old female, presents with a range of intrusive symptoms secondary to unmanaged Crohn's disease. These symptoms often interrupt Marta's work and sleep, causing anxiety. In this case study, we explore how Marta’s team prescribed a combination of medical cannabis products to treat her symptoms and improve her quality of life. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Explain the pathophysiology of Crohn’s disease and identify common management strategies  Discuss the potential benefits and limitations of medical cannabis as a treatment option for common symptoms of Crohn’s disease Identify suitable candidates for medical cannabis treatment Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management of symptoms of Crohn’s disease Devise treatment plans that consider patient safety and minimise risk Offer effective patient education and treatment advice on the therapeutic use of medical cannabis

Forty-four-year-old Helen experiences intermittent periods of neurological symptoms affecting motor function, speech and balance. After ruling out multiple sclerosis (MS), Helen's doctor diagnosed her with functional neurological disorder (FND.) Despite trialling several first-line treatments, Helen continues to relapse periodically and uses black-market medical cannabis oil to control symptoms, though the dosage is inconsistent as the product is homemade. In this case study, we explore how Dr. Xie prescribed medical cannabis products to help reduce the frequency of Helen's relapses. Estimated Duration: 1 hour Access Duration: 12 months from date of enrolment Learning Outcomes Upon completion of this module, you’ll be able to: Explain the pathophysiology of functional neurological disorder (FND) and identify common management strategies Discuss the potential benefits and limitations of medical cannabis as a treatment option for symptoms of FND Identify suitable candidates for medical cannabis treatment Devise treatment plans that consider patient safety and minimise risk Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in the management of FND

Peter, a 45-year-old with human immunodeficiency virus (HIV), is experiencing anxiety and insomnia as side effects of his current treatment regime. These side effects have caused Peter to feel significant fatigue, and he now finds it difficult to leave the house to participate in his regular social and community activities. In this case study, we explore how Dr. Xie prescribed medical cannabis products in addition to Peter’s current treatment regime to help manage his symptoms and get him out and about once more. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Explain the pathophysiology of Human immunodeficiency virus (HIV) and identify common management strategies  Discuss the potential benefits and limitations of medical cannabis as a treatment option for symptoms of HIV Identify suitable candidates for medical cannabis treatment Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in the management of symptoms of HIV Devise treatment plans that consider patient safety and minimise risk